Developing Practical Therapeutic Strategies that Target Protein SUMOylation
نویسندگان
چکیده
منابع مشابه
MicroRNAs that target RGS5
Objective(s):An earlier meta-analysis on gene expression data derived from four microarray, two cDNA library, and one SAGE experiment had identified RGS5 as one of only ten non-housekeeping genes that were reported to be expressed in human trabecular meshwork (TM) cells by all studies. RGS5 encodes regulator of G-protein signaling-5. The TM tissue is the route of aqueous fluid outflow, and is r...
متن کاملPractical Strategies for Developing Large Software Systems
In 1974, the major leverage point in the software process is at the software design and structuring stage. This stage begins with a statement of software requirements. Properly done, the software design and structuring process can identify the weak spots and mismatches in the requirements statement which are the main sources of unresponsiveness of delivered software. Once these weak spots slip ...
متن کاملmicrornas that target rgs5
objective(s):an earlier meta-analysis on gene expression data derived from four microarray, two cdna library, and one sage experiment had identified rgs5 as one of only ten non-housekeeping genes that were reported to be expressed in human trabecular meshwork (tm) cells by all studies. rgs5 encodes regulator of g-protein signaling-5. the tm tissue is the route of aqueous fluid outflow, and is r...
متن کاملProtein kinase C as a therapeutic target.
The recognition of protein kinase C (PKC) as the long soughtafter receptor for the tumor-promoting phorbol esters established the potential role of PKC in carcinogenesis and as a potentially important target for cancer therapeutics (1, 2). PKC is a family of serine/threonine kinases that regulate a variety of cell functions including proliferation, gene expression, cell cycle, differentiation, ...
متن کاملThe SUMOylation Pathway as a Potential Therapeutic Target in Multiple Myeloma
The Ubiquitin+Proteasome System (UPS) represents a successful anti-cancer strategy that has translated from preclinical studies to clinical development and significantly improved the survival of Multiple Myeloma (MM) patients (1). The proteasome is high molecular weight structure that contains multiple proteolytic sites and functions as the catalytic core of the UPS to degrade Ub~conjugated pro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Drug Targets
سال: 2019
ISSN: 1389-4501
DOI: 10.2174/1389450119666181026151802